Meys, R;
Purdie, KJ;
de Koning, MNC;
Quint, KD;
Little, A-M;
Baker, F;
Francis, N;
... Bunker, CB; + view all
(2016)
HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.
Journal of Infectious Diseases
, 213
(11)
pp. 1717-1724.
10.1093/infdis/jiw038.
Preview |
Text
Meys_ HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment_AAM.pdf - Accepted Version Download (561kB) | Preview |
Abstract
A proportion of human immunodeficiency virus (HIV)–infected patients develop persistent, stigmatizing human papillomavirus (HPV)–related cutaneous and genital warts and anogenital (pre)cancer. This is the first study to investigate immunogenetic variations that might account for HPV susceptibility and the largest to date to categorize the HPV types associated with cutaneous warts in HIV-positive patients. The HLA class I and II allele distribution was analyzed in 49 antiretroviral (ART)–treated HIV-positive patients with persistent warts, 42 noninfected controls, and 46 HIV-positive controls. The allele HLA-B*44 was more frequently identified in HIV-positive patients with warts (P = .004); a susceptible haplotype (HLA-B*44, HLA-C*05; P = .001) and protective genes (HLA-DQB1*06; P = .03) may also contribute. Cutaneous wart biopsy specimens from HIV-positive patients harbored common wart types HPV27/57, the unusual wart type HPV7, and an excess of Betapapillomavirus types (P = .002), compared with wart specimens from noninfected controls. These findings suggest that HLA testing might assist in stratifying those patients in whom vaccination should be recommended.
| Type: | Article |
|---|---|
| Title: | HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/infdis/jiw038 |
| Publisher version: | http://dx.doi.org/10.1093/infdis/jiw038 |
| Language: | English |
| Additional information: | Copyright © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. This is a pre-copyedited, author-produced version of an article accepted for publication in the Journal of Infectious Diseases following peer review. The version of record [Meys, R; Purdie, KJ; de Koning, MNC; Quint, KD; Little, A-M; Baker, F; Francis, N; (2016) HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment. Journal of Infectious Diseases , 213 (11) pp. 1717-1724. 10.1093/infdis/jiw038] is available online at: https://doi.org/10.1093/infdis/jiw038 |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Immunology, Infectious Diseases, Microbiology, human papillomavirus, HPV, human immunodeficiency virus, HIV, human leukocyte antigen, HLA, immunogenetics, warts, cutaneous warts, genital warts, Human-immunodeficiency-virus, 2/27/57-induced Common Warts, Class-ii Alleles, HPV Types, Cutaneous Warts, Cervical-cancer, Intraepithelial Neoplasia, Risk-factors, Skin, Prevalence |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1507986 |
Archive Staff Only
 |
View Item |
